Bare lymphocyte syndrome 2

Below you will find more information about Bare lymphocyte syndrome 2 from Medigest. If you believe that you are suffering from any of the symptoms of Bare lymphocyte syndrome 2 it is important that you obtain an accurate diagnosis from a medical professional to ensure that you obtain the correct medication or treatment for your condition. There are medical conditions that carry similar symptoms associated with Bare lymphocyte syndrome 2 and therefore the information provided by Medigest is offered as a guideline only and should never be used in preference to seeking professional medical advice. The information relating to Bare lymphocyte syndrome 2 comes from a third party source and Medigest will not be held liable for any inaccuracies relating to the information shown.

Definition

Bare lymphocyte syndrome 2 or the other term for the disease is Defective expression of HLA class 2. BLSII genetic basis is not because of the gene MHC II. The result of the mutations in genes is used as the genetic basis that codes for proteins that usually control the expression if the MHC II genes.

Prevalence

Bare lymphocyte syndrome type 2 is categorized as a "rare disease" according to the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This indicates that Bannayan-Zonana syndrome or a subtype of Bannayan-Zonana syndrome affects not more than 200,000 individuals in the US population.

Symptoms and Signs

Persistent diarrhea Malabsorption Mucocutaneous candidiasis Upper respiratory tract bacterial infection Lower respiratory tract bacterial infection Failure to thrive Fatigue Viral infections Fungal infections

Complications

If the disease is not treated early it may lead to an infant's death.

Discuss Bare lymphocyte syndrome 2 in our forums

Discuss Bare lymphocyte syndrome 2 with other members of Medigest in our forums.